Companies / BDX vs WST
BDX vs WST: Becton Dickinson and West Pharmaceutical Services
Becton Dickinson (BDX) reported $21.8B in revenue against a 7.7% net margin, while West Pharmaceutical Services (WST) reported $3.1B at a 16.1% net margin, most recently.
| Metric | BDX | WST |
|---|---|---|
| Revenue | $21.8B | $3.1B |
| Net Income | $1.7B | $0.5B |
| Gross Margin | 45.4% | 35.9% |
| Operating Margin | 11.8% | 19.0% |
| EPS (Diluted) | $5.82 | $6.79 |
| Free Cash Flow | $2.7B | $0.5B |
| Total Debt | $19.2B | $0.2B |
| P/E Ratio | 32.2× | 40.5× |
| P/B Ratio | n/m | 6.2× |
| Stock Price | $211.95 | $392.32 |
Free: last 5 years
| Fiscal year | FY2008 🔒 | FY2009 🔒 | FY2010 🔒 | FY2011 🔒 | FY2012 🔒 | FY2013 🔒 | FY2014 🔒 | FY2015 🔒 | FY2016 🔒 | FY2017 🔒 | FY2018 🔒 | FY2019 🔒 | FY2020 🔒 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BDX Revenue | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | $19.1B | $18.9B | $19.4B | $20.2B | $21.8B |
| WST Revenue | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | $2.8B | $2.9B | $2.9B | $2.9B | $3.1B |